AGRANULOCYTOSIS ASSOCIATED WITH AJMALIN THERAPY

Abstract
The case reports of five patients who developed agranulocytosis while taking the antiarrhythmic drug ajmalin are presented. All five responded rapidly to withdrawal of the drug and, in four of the five, antileucocyte ajmalin‐dependent activity was demonstrated in the serum by means of a leucocytotoxicity test.

This publication has 5 references indexed in Scilit: